Published Ahead of Print

March 23, 2023

You have access
Nuclear Medicine from a Novel Perspective: Buvat and Weber Talk with OpenAI's ChatGPT
Irène Buvat and Wolfgang Weber

Journal of Nuclear Medicine March 23, 2023, jnumed.123.265636; DOI: https://doi.org/10.2967/jnumed.123.265636
You have access
Summary: Appropriate Use Criteria for Lymphoscintigraphy in Sentinel Node Mapping and Lymphedema/Lipedema
Kevin J. Donohoe, Brett J. Carroll, David K.V. Chung, Elizabeth H. Dibble, Emilia Diego, Francesco Giammarile, Frederick D. Grant, Stephen Y. Lai, Hannah Linden, Megan E. Miller, Neeta Pandit-Taskar, Nicholas E. Tawa and Sergi Vidal-Sicart

Journal of Nuclear Medicine March 23, 2023, jnumed.123.265560; DOI: https://doi.org/10.2967/jnumed.123.265560
You have access
Amyloid Imaging–Based Food and Drug Administration Approval of Lecanemab to Treat Alzheimer Disease—What Lasts Long Finally Becomes Good?
Henryk Barthel

Journal of Nuclear Medicine March 23, 2023, jnumed.123.265667; DOI: https://doi.org/10.2967/jnumed.123.265667
You have access
Could FAP-Targeted Molecular Imaging Replace ¹⁸F-FDG for Standard-of-Care Oncologic PET?
Raghava Kashyap and Aravind S. Ravi Kumar

Journal of Nuclear Medicine March 23, 2023, jnumed.122.265003; DOI: https://doi.org/10.2967/jnumed.122.265003

February 9, 2023

You have access
Radioimmunoscintigraphy and pre-treatment dosimetry of ¹³¹I-omburtamab for planning treatment of leptomeningeal disease
Neeta Pandit-Taskar, Milan Grkovski, Pat B. Zanzonico, Keith S. Pentlow, Shakeel Modak, Kim Kramer and John L. Humm

Journal of Nuclear Medicine February 9, 2023, jnumed.122.265131; DOI: https://doi.org/10.2967/jnumed.122.265131
You have access
The emergence of somatostatin antagonist-based theranostics: Paving the road toward another success?
Alessio Imperiale, Abhishek Jha, Leah Meuter, Guillaume P Nicolas, David Taïeb and Karel Pacak

Journal of Nuclear Medicine February 9, 2023, jnumed.123.265406; DOI: https://doi.org/10.2967/jnumed.123.265406
You have access
¹⁶¹Tb-PSMA Radioligand Therapy: First-in-human SPECT/CT Imaging
Akram Al-Ibraheem, Rahma M. Doudeen, Diyaa Juaidi, Alaa Abufara and Stephan Maus

Journal of Nuclear Medicine February 9, 2023, jnumed.122.265291; DOI: https://doi.org/10.2967/jnumed.122.265291
You have access
PSMA PET/CT–based Atlas for Prostatic Bed Recurrence after Radical Prostatectomy: Clinical Implications for Salvage Radiation Therapy Contouring Guidelines
Ida Sonni, Alan Dal Pra, Dylan P. O'Connell, Zachary Ells, Matthias Benz, Kathleen Nguyen, Stephanie M. Yoon, Jie Deng, Clayton Smith, Tristan Grogan, Nickolas G. Nickols, Minsong Cao, Amar U. Kishan and Jeremie Calais

Journal of Nuclear Medicine February 9, 2023, jnumed.122.265025; DOI: https://doi.org/10.2967/jnumed.122.265025
Open Access
PSMA-GCK01 - A Generator-Based ^99mTc-/¹⁸⁸Re-Theranostic Ligand for the Prostate-Specific Membrane Antigen
Jens Cardinale, Frederik L. Giesel, Christina Wensky, Hendrik G. Rathke, Uwe Haberkorn and Clemens Kratochwil

Journal of Nuclear Medicine February 9, 2023, jnumed.122.264944; DOI: https://doi.org/10.2967/jnumed.122.264944

February 2, 2023

You have access
Efficacy and safety of ¹²⁴I-mIBG dosimetry-guided high activity ¹³¹I-mIBG therapy of advanced pheochromocytoma or neuroblastoma
Ines Maric, Manuel Weber, Andre Prochnow, Jochen Schmitz, Nicole Unger, Benedikt M. Schaarschmidt, Thorsten D. Poeppel, Christoph Rischpler, Andreas Bockisch, Ken Herrmann, Walter Jentzen and Wolfgang P. Fendler

Journal of Nuclear Medicine February 2, 2023, jnumed.122.264775; DOI: https://doi.org/10.2967/jnumed.122.264775
You have access
Functional imaging of chemo-brain: usefulness of Nuclear Medicine in the fog coming after cancer
Agostino Chiaravalloti, Luca Filippi, Marco Pagani and Orazio Schillaci

Journal of Nuclear Medicine February 2, 2023, jnumed.121.263294; DOI: https://doi.org/10.2967/jnumed.121.263294
You have access
Consecutive PSMA and AR PET imaging shows positive correlation to AR and PSMA protein expression in primary hormone naïve prostate cancer.
Valentin al Jalali, Gabriel Wasinger, Sazan Rasul, Bernhard Grubmueller, Beatrix Wulkersdorfer, Theresa Balber, Markus Mitterhauser, Judit Simon, Marcus Hacker, Sharokh Shariat, Gerda Egger and Markus Zeitlinger

Journal of Nuclear Medicine February 2, 2023, jnumed.122.264981; DOI: https://doi.org/10.2967/jnumed.122.264981
You have access
An analysis of PSMA-PET/CT-positive lymph node distribution and their coverage by different elective nodal radiation volumes in postoperative prostate cancer patients
Christian Trapp, Dmytro Oliinyk, Paul Rogowski, Rieke Von Bestenbostel, Ute Ganswindt, Minglun Li, Chukwuka Eze, Peter Bartenstein, Leonie Beyer, Harun Ilhan, Gabriel Sheikh, Lena Unterrainer, Christian Stief, Thilo Westhofen, Wolfgang G. Kunz, Marcus Unterrainer, Claus Belka and Nina-Sophie Schmidt-Hegemann

Journal of Nuclear Medicine February 2, 2023, jnumed.122.265159; DOI: https://doi.org/10.2967/jnumed.122.265159
Open Access
Signaling Network Response to Alpha-Particle Targeted Therapy with Actinium-225 Labeled Minigastrin Analogue ²²⁵Ac-PP-F11N Reveals Radiosensitizing Potential of HDAC Inhibitors
Yun Qin, Stefan Imobersteg, Stephan Frank, Alain Blanc, Tanja Chiorazzo, Philipp Berger, Roger Schibli, Martin P. Béhé and Michal Grzmil

Journal of Nuclear Medicine February 2, 2023, jnumed.122.264597; DOI: https://doi.org/10.2967/jnumed.122.264597

January 26, 2023

You have access
Radiolabeled GPVI-Fc for PET imaging of multiple extracellular matrix fibers: A new look into pulmonary fibrosis progression.
Simon Isser, Andreas Maurer, Gerald Reischl, Martin Schaller, Irene Gonzalez-Menendez, Leticia Quintanilla-Martinez, Meinrad Gawaz, Bernd J. Pichler and Nicolas Beziere

Journal of Nuclear Medicine January 26, 2023, jnumed.122.264552; DOI: https://doi.org/10.2967/jnumed.122.264552
You have access
Incidental detection of a tenosynovial giant cell tumour of the thigh on [⁶⁸Ga]Ga-FAPI PET/CT: presentation of an unusual case
Timur Sellmann, Felicitas Staak, Clemens Maurer, Gernot Rott, Oliver Witzke, Wolfgang Fendler, Hans-Ulrich Schildhaus, Lars Erik Podleska, Ken Herrmann and Christoph Rischpler

Journal of Nuclear Medicine January 26, 2023, jnumed.118.207761; DOI: https://doi.org/10.2967/jnumed.118.207761

January 19, 2023

You have access
Preliminary clinical experience of cholecystokinin-2 receptor PET/CT imaging using the ⁶⁸Ga-labeled minigastrin analog DOTA-MGS5 in patients with medullary thyroid cancer
Elisabeth von Guggenberg, Christian Uprimny, Maximilian Klingler, Boris Warwitz, Anna Sviridenko, Steffen Bayerschmidt, Gianpaolo Di Santo and Irene J. Virgolini

Journal of Nuclear Medicine January 19, 2023, jnumed.122.264977; DOI: https://doi.org/10.2967/jnumed.122.264977
Open Access
Towards Single Time Point Image-Based Dosimetry of ¹⁷⁷Lu-PSMA-617 Therapy
Julia Brosch-Lenz, Astrid Delker, Friederike Völter, Lena M Unterrainer, Lena Kaiser, Peter Bartenstein, Sibylle Ziegler, Arman Rahmim, Carlos Uribe and Guido Böning

Journal of Nuclear Medicine January 19, 2023, jnumed.122.264594; DOI: https://doi.org/10.2967/jnumed.122.264594
Open Access
Molecular imaging of pulmonary inflammation in electronic and combustible cigarette users: a pilot study
Reagan R. Wetherill, Robert K. Doot, Anthony J. Young, Hsiaoju Lee, Erin K. Schubert, Corinde E. Wiers, Frank T. Leone, Robert H. Mach, Henry R. Kranzler and Jacob G. Dubroff

Journal of Nuclear Medicine January 19, 2023, jnumed.122.264529; DOI: https://doi.org/10.2967/jnumed.122.264529

January 12, 2023

Open Access
Prostate-Specific Membrane Antigen Expression on Positron Emission Tomography/Computed Tomography in Patients with Metastatic Castration-Resistant Prostate Cancer: A Retrospective Observational Study
Letizia Calderoni, Elisa Maietti, Andrea Farolfi, Riccardo Mei, Karly S. Louie, Michael Groaning and Stefano Fanti

Journal of Nuclear Medicine January 12, 2023, jnumed.122.264964; DOI: https://doi.org/10.2967/jnumed.122.264964
You have access
Incidental focal ⁶⁸Ga-FAPI-46 uptake in a urachal remnant: a potential pitfall mimicking a malignant peritoneal lesion.
Peter George Maliha, Mahbod Jafarvand, Johannes Czernin, Jérémie Calais and Masatoshi Hotta

Journal of Nuclear Medicine January 12, 2023, jnumed.122.265029; DOI: https://doi.org/10.2967/jnumed.122.265029
Open Access
Developing a novel patient reported outcomes measure for prostate cancer patients receiving radionuclide therapy
Lisa M. Gudenkauf, Melody Chavez, Melinda L. Maconi, Carley Geiss, Ameen Seyedroudbari, Pan Thin, Aasha I. Hoogland, Kathleen Nguyen, Vishnu Murthy, Wesley R. Armstrong, Khaled Komrokji, Laura B. Oswald, Heather S.L. Jim, Ghassan El-Haddad, Wolfgang Peter Fendler, Ken Herrmann, David Cella, Johannes Czernin, Michael S. Hofman, Adam P. Dicker, Jeremie Calais, Scott T. Tagawa and Brian D. Gonzalez

Journal of Nuclear Medicine January 12, 2023, jnumed.122.264946; DOI: https://doi.org/10.2967/jnumed.122.264946

January 5, 2023

You have access
Long-term prognostic value of 82Rubidium PET/CT-determined myocardial perfusion and flow reserve in cancer patients
Josef J. Fox, Audrey Mauguen, Kimiteru Ito, Dipti Gupta, Alice Yu, Thomas H. Schindler, H. William Strauss and Heiko Schöder

Journal of Nuclear Medicine January 5, 2023, jnumed.122.264795; DOI: https://doi.org/10.2967/jnumed.122.264795
You have access
Incidental Airway Findings on PET/CT with F-18 PSMA
Jason Orciuolo, Akash Sharma, Ephraim E. Parent, Joseph M. Accurso, Manoj K. Jain and Jason R. Young

Journal of Nuclear Medicine January 5, 2023, jnumed.122.265270; DOI: https://doi.org/10.2967/jnumed.122.265270
You have access
First total-body kinetic modeling and parametric imaging of dynamic ⁶⁸Ga-FAPI-04 PET in pancreatic and gastric cancer
Ruohua Chen, Xinlan Yang, Yee Ling Ng, Xiaofeng Yu, Yanmiao Huo, Xiuying Xiao, Chenpeng Zhang, Yumei Chen, Chaojie Zheng, Lianghua Li, Gang Huang, Yun Zhou and Jianjun Liu

Journal of Nuclear Medicine January 5, 2023, jnumed.122.264988; DOI: https://doi.org/10.2967/jnumed.122.264988
You have access
Myocardial external efficiency in asymptomatic severe primary mitral regurgitation using ¹¹C-acetate positron emission tomography
Jens Sorensen, Johannes Bergsten, Tomasz Baron, Lovisa Holm Orndahl, Tanja Kero, Tomas Bjerner, Eva-Maria Hedin, Hendrik J. Harms, Rafael Astudillo and Frank A. Flachskampf

Journal of Nuclear Medicine January 5, 2023, jnumed.122.264945; DOI: https://doi.org/10.2967/jnumed.122.264945
You have access
Detection of early esophageal neoplastic Barrett lesions with quantified fluorescence molecular endoscopy using cetuximab-800CW
Ruben Y. Gabriels, Lisanne E. van Heijst, Wouter T. R. Hooghiemstra, Anne M. van der Waaij, Gursah Kats-Ugurlu, Arend Karrenbeld, Dominic J. Robinson, Anna Tenditnaya, Vasilis Ntziachristos, Dimitris Gorpas and Wouter B. Nagengast

Journal of Nuclear Medicine January 5, 2023, jnumed.122.264656; DOI: https://doi.org/10.2967/jnumed.122.264656
You have access
The Latest Advances in Peptide Receptor Radionuclide Therapy for Gastroenteropancreatic Neuroendocrine Tumors
Elif Hindié, Eric Baudin, Rodney Hicks and David Taïeb

Journal of Nuclear Medicine January 5, 2023, jnumed.122.264422; DOI: https://doi.org/10.2967/jnumed.122.264422

December 29, 2022

You have access
The prognostic role of ⁶⁸Ga-PSMA11 PET-based response in prostate cancer patients undergoing taxane-based chemotherapy
Lukas Lunger, Maythinee Chantadisai, Amir Karimzadeh, Isabel Rauscher, Calogero D'Alessandria, Benedikt Feuerecker, Thomas Langbein, Robert Tauber, Stefan Schiele, Wolfgang Andreas Weber and Matthias Eiber

Journal of Nuclear Medicine December 29, 2022, jnumed.122.264962; DOI: https://doi.org/10.2967/jnumed.122.264962
You have access
Prognostic value of ¹⁸F-FDG PET/CT in diffuse large B-cell lymphoma treated with a risk-adapted immunochemotherapy regimen
Laure Michaud, Kurt Bantilan, Audrey Mauguen, Craig H. Moskowitz, Andrew D. Zelenetz and Heiko Schöder

Journal of Nuclear Medicine December 29, 2022, jnumed.122.264740; DOI: https://doi.org/10.2967/jnumed.122.264740
Open Access
Submillimeter resolution positron emission tomography for high-sensitivity mouse brain imaging
Han Gyu Kang, Hideaki Tashima, Hidekatsu Wakizaka, Fumihiko Nishikido, Makoto Higuchi, Miwako Takahashi and Taiga Yamaya

Journal of Nuclear Medicine December 29, 2022, jnumed.122.264433; DOI: https://doi.org/10.2967/jnumed.122.264433
You have access
Fibroblast activation protein positron emission tomography and histopathology in a single-center database of 324 patients and 21 tumor entities
Nader Hirmas, Rainer Hamacher, Miriam Sraieb, Marc Ingenwerth, Lukas Kessler, Kim M. Pabst, Francesco Barbato, Katharina Lueckerath, Stefan Kasper, Michael Nader, Hans-Ulrich Schildhaus, Claudia Kesch, Bastian von Tresckow, Christine Hanoun, Hubertus Hautzel, Clemens Aigner, Martin Glas, Martin Stuschke, Sherko Kuemmel, Philipp Harter, Celine Lugnier, Waldemar Uhl, Marco Niedergethmann, Boris Hadaschik, Viktor Gruenwald, Jens T. Siveke, Ken Herrmann and Wolfgang P. Fendler

Journal of Nuclear Medicine December 29, 2022, jnumed.122.264689; DOI: https://doi.org/10.2967/jnumed.122.264689

December 22, 2022

You have access
Distinguishing Progression from Pseudoprogression in Glioblastoma Using ¹⁸F-Fluciclovine PET
Ali Nabavizadeh, Stephen J Bagley, Robert K. Doot, Jeffrey B Ware, Anthony J. Young, Satyam Ghodasara, Chao Zhao, Hannah Anderson, Erin Schubert, Erica L. Carpenter, Jacob Till, Fraser Henderson, Austin R. Pantel, H. Isaac Chen, John Y. K. Lee, Nduka M. Amankulor, Donald M. O'Rourke, Arati Desai, MacLean P. Nasrallah and Steven Brem

Journal of Nuclear Medicine December 22, 2022, jnumed.122.264812; DOI: https://doi.org/10.2967/jnumed.122.264812

December 15, 2022

Open Access
Imaging Diverse Pathogenic Bacteria in vivo with [¹⁸F]fluoromannitol Positron Emission Tomography
Spenser R. Simpson, Alexandria E. Kesterson, Justin H. Wilde, Zoraiz Qureshi, Bijoy K Kundu, Mark P. Simons and Kiel D. Neumann

Journal of Nuclear Medicine December 15, 2022, jnumed.122.264854; DOI: https://doi.org/10.2967/jnumed.122.264854
You have access
Left Ventricular Strain from Myocardial Perfusion Positron Emission Tomography imaging: Method Development and Comparison to 2-Dimensional Echocardiography
Jingwen Huang, Adam J. Mitchell, Ernest V. Garcia, C. David Cooke, Russell Folks, Maria Pernetz, Abhinav Goyal, Marina Piccinelli and Jonathon A Nye

Journal of Nuclear Medicine December 15, 2022, jnumed.122.264516; DOI: https://doi.org/10.2967/jnumed.122.264516
You have access
Is ¹⁸F-FDG PET needed to assess ¹⁷⁷Lu-PSMA Therapy Eligibility? A VISION-like, Single-Center Analysis
Robert Seifert, Tugce Telli, Boris Hadaschik, Wolfgang Peter Fendler, Phillip H. Kuo and Ken Herrmann

Journal of Nuclear Medicine December 15, 2022, jnumed.122.264741; DOI: https://doi.org/10.2967/jnumed.122.264741

December 8, 2022

You have access
Biodistribution, Dosimetry, and Pharmacokinetics of ⁶⁸Ga-CBP8: A type I collagen targeted PET probe
David Izquierdo-Garcia, Pauline Désogère, Mariane Le Fur, Sergey Shuvaev, Iris Y. Zhou, Ian Ramsay, Michael Lanuti, Onofrio Catalano, Ciprian Catana, Peter Caravan and Sydney B Montesi

Journal of Nuclear Medicine December 8, 2022, jnumed.122.264530; DOI: https://doi.org/10.2967/jnumed.122.264530
You have access
Fibroblast activation protein targeted radioligand therapy for treatment of solid tumors
Spencer Dirk Lindeman, Ramesh Mukkamala, Autumn Horner, Pooja Tudi, Owen Christopher Booth, Roxanne Rato Huff, Joshua Hinsey, Anders Hovstadius, Peter Martone, Fenghua Zhang, Madduri Srinivasarao, Abigail Cox and Philip S. Low

Journal of Nuclear Medicine December 8, 2022, jnumed.122.264494; DOI: https://doi.org/10.2967/jnumed.122.264494
You have access
Tau PET Visual Reads: Research and Clinical Applications and Future Directions
David N. Soleimani-Meigooni and Gil D. Rabinovici

Journal of Nuclear Medicine December 8, 2022, jnumed.122.265017; DOI: https://doi.org/10.2967/jnumed.122.265017
You have access
Dosimetric variability across a library of computational tumor phantoms
Lukas M. Carter, Simone Krebs, Harry Marquis, Juan Camilo Ocampo Ramos, Edmond A. Olguin, Emilia O. Mason, Wesley E. Bolch, Pat B. Zanzonico and Adam Leon Kesner

Journal of Nuclear Medicine December 8, 2022, jnumed.122.264916; DOI: https://doi.org/10.2967/jnumed.122.264916

December 2, 2022

You have access
⁶⁴Cu Treatment Planning and ⁶⁷Cu Therapy with Radiolabelled SARTATE ([⁶⁴Cu/⁶⁷Cu]MeCOSAR-Octreotate) in Subjects with Unresectable Multifocal Meningioma – Initial Results for Human Imaging, Safety, Biodistribution and Radiation Dosimetry
Dale L Bailey, Kathy P Willowson, Matt Harris, Colin Biggin, Alireza Aslani, Nigel A Lengkeek, Jon Stoner, M Enid Eslick, Harry Marquis, Michelle Parker, Paul J Roach and Geoffrey P Schembri

Journal of Nuclear Medicine December 2, 2022, jnumed.122.264586; DOI: https://doi.org/10.2967/jnumed.122.264586
You have access
Non-specific PSMA-1007 bone uptake evaluated through PSMA-11 PET, bone scan and MRI triple validation in patients with biochemical recurrence of prostate cancer
Robert Seifert, Tugce Telli, Marcel Opitz, Francesco Barbato, Christoph Berliner, Michael Nader, Lale Umutlu, Martin Stuschke, Boris Hadaschik, Ken Herrmann and Wolfgang P. Fendler

Journal of Nuclear Medicine December 2, 2022, jnumed.118.215434; DOI: https://doi.org/10.2967/jnumed.118.215434
You have access
Diagnostic utility of amino acid PET in the differential diagnosis of recurrent brain metastases and treatment-related changes: a meta-analysis
Timo Schlürmann, Birgit Waschulzik, Stephanie Combs, Jens Gempt, Benedikt Wiestler, Wolfgang Weber and Igor Yakushev

Journal of Nuclear Medicine December 2, 2022, jnumed.122.264803; DOI: https://doi.org/10.2967/jnumed.122.264803

November 23, 2022

You have access
Radioiodine ablation of thyroid remnants in patients with Graves’ orbitopathy
Michael Oeverhaus, Jana Koenen, Nikolaos Bechrakis, Mareile Stöhr, Ken Herrmann, Wolfgang Peter Fendler, Anja Eckstein and Manuel Weber

Journal of Nuclear Medicine November 23, 2022, jnumed.122.264660; DOI: https://doi.org/10.2967/jnumed.122.264660
You have access
Noninvasive assessment of human epidermal growth factor receptor 2 (HER2) in esophagogastric cancer using ⁸⁹Zr-trastuzumab PET: a pilot study
Melissa Amy Lumish, Steven B. Maron, Viktoriya Paroder, Joanne F. Chou, Marinela Capanu, Steven Philemond, Joseph A. O'Donoghue, Heiko Schöder, Jason S. Lewis, Serge K. Lyaschenko, Neeta Pandit-Taskar and Yelena Y. Janjigian

Journal of Nuclear Medicine November 23, 2022, jnumed.122.264470; DOI: https://doi.org/10.2967/jnumed.122.264470
You have access
A multicenter study on observed discrepancies between vendor-stated and PET measured ⁹⁰Y activities for both glass and resin microsphere devices
Silvano Gnesin, Justin K. Mikell, Maurizio Conti, John O. Prior, Thomas Carlier, Thiago V. M. Lima and Yuni K. Dewaraja

Journal of Nuclear Medicine November 23, 2022, jnumed.122.264458; DOI: https://doi.org/10.2967/jnumed.122.264458
Open Access
Phase III study of ¹⁸F-PSMA-1007 versus ¹⁸F-fluorocholine PET/CT for localization of prostate cancer biochemical recurrence: a prospective, randomized, cross-over, multicenter study
Pierre Olivier, Anne-Laure Giraudet, Andrea Skanjeti, Charles Merlin, Pierre Weinmann, Ines Rudolph, Alexander Hoepping and Mathieu Gauthé

Journal of Nuclear Medicine November 23, 2022, jnumed.122.264743; DOI: https://doi.org/10.2967/jnumed.122.264743

November 17, 2022

You have access
3-time-point PET-analysis of FAPI-46 in a variety of cancers
Mahnoosh Naeimi, Peter L. Choyke, Katharina Dendl, Yuriko Mori, Fabian Staudinger, Tadashi Watabe, Stefan A Koerber, Manuel Röhrich, Juergen Debus, Clemens Kratochwil, Uwe A. Haberkorn and Frederik L Giesel

Journal of Nuclear Medicine November 17, 2022, jnumed.122.264941; DOI: https://doi.org/10.2967/jnumed.122.264941
Open Access
²²⁵Ac-Macropatate: A Novel Alpha Particle Peptide Receptor Radionuclide Therapy for Neuroendocrine Tumors
A. Paden King, Nicholas T. Gutsche, Natarajan Raju, Stanley Fayn, Kwamena E. Baidoo, Meghan M. Bell, Colleen S. Olkowski, Rolf E. Swenson, Frank I. Lin, Samira M. Sadowski, Stephen S. Adler, Nikki A. Thiele, Justin J. Wilson, Peter L. Choyke and Freddy E. Escorcia

Journal of Nuclear Medicine November 17, 2022, jnumed.122.264707; DOI: https://doi.org/10.2967/jnumed.122.264707
You have access
Interim analysis of a prospective validation of two blood-based genomic assessments (PPQ and NETest) to determine clinical efficacy of ¹⁷⁷Lu-DOTATATE in neuroendocrine tumors
Lisa Bodei, Nitya Raj, Richard K. Do, Audrey Mauguen, Simone Krebs, Diane Reidy-Lagunes and Heiko Schöder

Journal of Nuclear Medicine November 17, 2022, jnumed.122.264363; DOI: https://doi.org/10.2967/jnumed.122.264363

Main menu

User menu

Search

Published Ahead of Print

March 23, 2023

February 9, 2023

February 2, 2023

January 26, 2023

January 19, 2023

January 12, 2023

January 5, 2023

December 29, 2022

December 22, 2022

December 15, 2022

December 8, 2022

December 2, 2022

November 23, 2022

November 17, 2022

Pages